BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23098039)

  • 1. Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach.
    Märtens B; Janssen S; Werner M; Frühauf J; Christiansen H; Bremer M; Steinmann D
    BMC Cancer; 2012 Oct; 12():497. PubMed ID: 23098039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approach.
    Steinmann D; Maertens B; Janssen S; Werner M; Frühauf J; Nakamura M; Christiansen H; Bremer M
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1523-9. PubMed ID: 22526164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
    Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.
    Mengue L; Bertaut A; Ngo Mbus L; Doré M; Ayadi M; Clément-Colmou K; Claude L; Carrie C; Laude C; Tanguy R; Blanc J; Sunyach MP
    Radiat Oncol; 2020 Apr; 15(1):82. PubMed ID: 32303236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts.
    Fahrig A; Ganslandt O; Lambrecht U; Grabenbauer G; Kleinert G; Sauer R; Hamm K
    Strahlenther Onkol; 2007 Nov; 183(11):625-30. PubMed ID: 17960338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HFSRT of the resection cavity in patients with brain metastases.
    Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
    Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.
    Heisterkamp C; Haatanen T; Schild SE; Rades D
    Strahlenther Onkol; 2010 Feb; 186(2):70-75. PubMed ID: 20127223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival.
    Sallabanda M; García-Berrocal MI; Romero J; García-Jarabo V; Expósito MJ; Rincón DF; Zapata I; Magallón MR
    Clin Transl Oncol; 2020 Oct; 22(10):1809-1817. PubMed ID: 32124243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
    Di Perri D; Tanguy R; Malet C; Robert A; Sunyach MP
    J Neurooncol; 2020 Sep; 149(3):447-453. PubMed ID: 32979130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
    Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
    Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluatıon of hypofractıonated stereotactıc radıotherapy (HFSRT) to the resectıon cavıty after surgıcal resectıon of braın metastases: A sıngle center experıence.
    Dincoglan F; Sager O; Uysal B; Demiral S; Gamsiz H; Gündem E; Elcim Y; Dirican B; Beyzadeoglu M
    Indian J Cancer; 2019; 56(3):202-206. PubMed ID: 31389381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
    Vordermark D; Kölbl O; Ruprecht K; Vince GH; Bratengeier K; Flentje M
    BMC Cancer; 2005 May; 5():55. PubMed ID: 15924621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs.
    Nieder C; Leicht A; Motaref B; Nestle U; Niewald M; Schnabel K
    Am J Clin Oncol; 1999 Dec; 22(6):573-9. PubMed ID: 10597741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of hypofractionated stereotactic radiotherapy for brain metastases using three fractions: A single-centre retrospective study.
    Vigneau E; Jacquemin J; Benadon B; Dat Nguyen T; Marchand-Créty C
    Cancer Radiother; 2021 Dec; 25(8):763-770. PubMed ID: 34083125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
    Rades D; Heisterkamp C; Schild SE
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):398-403. PubMed ID: 20488627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases.
    Giubilei C; Ingrosso G; D'Andrea M; Benassi M; Santoni R
    J Neurooncol; 2009 Jan; 91(2):207-12. PubMed ID: 18807149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity.
    Ernst-Stecken A; Ganslandt O; Lambrecht U; Sauer R; Grabenbauer G
    Radiother Oncol; 2006 Oct; 81(1):18-24. PubMed ID: 16978720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.